Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;53:909-911
Published online before print April 27, 2009, doi: 10.1161/HYPERTENSIONAHA.109.130427
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
53/6/909    most recent
HYPERTENSIONAHA.109.130427v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wesseling, S.
Right arrow Articles by Joles, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wesseling, S.
Right arrow Articles by Joles, J. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Coronary Artery Disease
*Dietary Supplements
Related Collections
Right arrow Nutrition
Right arrow Animal models of human disease
Right arrow Risk Factors
Right arrow Coronary circulation
Right arrow Lipid and lipoprotein metabolism
Right arrowRelated Article

(Hypertension. 2009;53:909.)
© 2009 American Heart Association, Inc.


Editorial Commentaries

Taurine

Red Bull or Red Herring?

Sebastiaan Wesseling; Maarten P. Koeners; Jaap A. Joles

From the Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.

Correspondence to Jaap A. Joles, Department of Nephrology and Hypertension F03.223, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands. E-mail j.a.joles@umcutrecht.nl


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Taurine, a sulfur-containing amino acid (Figure), has been termed a functional nutrient that could be used to protect against, among others, diabetes mellitus and atherosclerosis.1 Indeed, an increasing body of literature supports the use of taurine supplements. Because taurine has very diverse functions, notably, intracellular osmoregulation and bile acid formation, and is abundantly present in several organs, multiple pathways could be involved. Some of these are discussed in this editorial.


Figure Removed (Available Only in the Full Text)
View larger version (11K):



 
Figure. A simplified biosynthesis pathway from methionine to taurine. Methionine is converted to homocysteine in 3 steps. Homocysteine is used as a substrate to form cysteine in 2 steps but can also be converted back to methionine by 2 different mechanisms. Cysteine, precursor for the important antioxidant glutathione and the gaseous transmitter/signaling molecule H2S, can be further converted to cysteine sulfinate. Cysteine sulfinate is converted to taurine in 2 steps via 2 different pathways. Taurine can decrease methionine by decreasing uptake. Whether taurine decreases homocysteine directly or via a reduction of methionine is unclear.

Of the 20 canonical amino acids, 18 are composed of carbon, hydrogen, nitrogen, and oxygen only. The remaining 2, methionine and cysteine, also contain 1 atom of sulfur. Because sulfur is not as electronegative as oxygen, the sulfur-containing amino acids play a key role in protein structure and synthesis.2 Methionine and cysteine also play important roles in cell metabolism. For instance, methionine serves as a substrate for S-adenosylmethionine, which is vital for methylation of nucleic acids, proteins, lipids, etc. In proteins, cysteine easily . . . [Full Text of this Article]


Related Article:

High Dietary Taurine Reduces Apoptosis and Atherosclerosis in the Left Main Coronary Artery: Association With Reduced CCAAT/Enhancer Binding Protein Homologous Protein and Total Plasma Homocysteine but not Lipidemia
Anthony Zulli, Eza Lau, Bagus P.P. Wijaya, Xin Jin, Komang Sutarga, Grace D. Schwartz, Jonathon Learmont, Peter J. Wookey, Angelo Zinellu, Ciriaco Carru, and David L. Hare
Hypertension 2009 53: 1017-1022. [Abstract] [Full Text] [PDF]